Two grants have been awarded via The Hope Foundation’s SWOG Early Exploration and Development (SEED) Fund.

Awards are made from The Hope Foundation SEED Fund to encourage preliminary research that will potentially translate to future clinical trials or trial-associated projects (translational medicine studies) within SWOG and the National Clinical Trials Network (NCTN). These grants may assist investigators with projects that support various types of studies, such as: preclinical data, secondary data analysis from clinical trials, pilot and feasibility studies (including early stage clinical trials), small, self-contained research projects, or development of research methodology/technology.

This first round of SEED grants fund the following research:

  • “Rational Targeting of the MAPK Pathway in Atypical RAS Mutant Colorectal Cancer in Next Generation Preclinical Models”
    Dr. Christopher Lieu of the University of Colorado Denver and Dr. Scott Kopetz of MD Anderson Cancer Center lead this collaborative project gathering preclinical data which will potentially result in a clinical trial concept for the SWOG Gastrointestinal Malignancies Group.
  • “Developing an education program to reduce weight gain during adjuvant treatment for breast cancer”
    Dr. Heather Greenlee of Columbia University heads a team of collaborators whose work for this project builds upon S1008: Feasibility Study of Physical Activity and Dietary Change Weight Loss Intervention in Breast and Colorectal Cancer Survivors, Phase II.